Cortavance 76ml

Cortavance 76ml

Cortavance is a topical spray used for the symptomatic treatment of inflammatory and pruritic dermatoses in dogs and is most commonly associated with treating itchy skin. Cortavance is a non-steroidal anti-inflammatory drug (NSAID).

The spray is a cutaneous spray solution and contains the active substance hydrocortisone aceponate which provides relief from both inflammation and pruritus leading to a quick improvement of skin lesions observed in case of inflammatory and pruritic dermatosis.

How To Buy Cortavance 76ml For Dogs

Cortavance spray is a prescription-only medication. This means that before you complete your purchase, you are required to upload a prescription through our online portal.

Once our team has confirmed you've ordered the right medication for your dog, we will send out your order. It's a simple process that means you can buy Cortavance online instead of going to your vet every month.

How To Use Cortavance Spray

Presented as a volatile spray, this veterinary medicinal product does not require any massage. Cortavance Spray can be applied by activating the pump spray, from a distance of about 10 cm of the area to be treated.

The recommended dosage is 1.52 μg of hydrocortisone aceponate/cm2 of affected skin per day. This dosage can be achieved with two pump spray activations over a surface to be treated equivalent to a square of 10 cm x 10 cm.

For treatment of inflammatory and pruritic dermatoses, repeat the treatment daily for 7 consecutive days.

Special Precautions

Clinical signs of atopic dermatitis such as pruritus and skin inflammation are not specific to this disease and therefore other causes of dermatitis such as ectoparasitic infestations and infections which cause dermatological signs should be ruled out before treatment is started, and underlying causes should be investigated.

In the case of concurrent microbial disease or parasitic infestation, the dog should receive appropriate treatment for such a condition.

In the absence of specific information, the use in animals suffering from Cushing’s syndrome shall be based on the risk-benefit assessment.

Since glucocorticosteroids are known to slow growth, use in young animals (under 7 months of age) shall be based on the risk-benefit assessment and subject to regular clinical evaluations.

Total body surface treated should not exceed approximately 1/3 of the dog’s surface corresponding for example to a treatment of two flanks from the spine to the mammary chains including the shoulders and the thighs. Otherwise, use only according to the risk-benefit assessment of the responsible veterinary surgeon and subject the dog to regular clinical evaluations as further described below.

Care should be taken to avoid spraying into the eyes of the animal.

Target species

Dogs

Indications for use

For symptomatic treatment of inflammatory and pruritic dermatoses in dogs.

Contra-indications

Do not use on cutaneous ulcers.

Special warnings for each target species

Total body surface treated should not exceed a surface corresponding for example to a treatment of two flanks from the spine to the mammary chains including the shoulders and the thighs. Otherwise, use only according to the risk-benefit assessment and subject the dog to regular clinical evaluations.

Special precautions for use in animals

In the case of concurrent microbial disease or parasitic infestation, the dog should receive appropriate treatment for such conditions. In the absence of specific information, the use in animals suffering from Cushing’s syndrome shall be based on the risk-benefit assessment. Since glucocorticosteroids are known to slow growth, use in young animals (under 7 months of age) shall be based on the risk-benefit assessment and subject to regular clinical evaluations.

In 12 dogs suffering from atopic dermatitis, after topical application on the skin at the recommended therapeutic dosage for 28 to 70 consecutive days, no noticeable effect on the systemic cortisol level was observed.

Special precautions to be taken by the person administering the veterinary medicinal product to animals

In case of accidental skin contact, it is recommended to wash thoroughly with water. Wash hands after use.

Avoid contact with eyes. In case of accidental eye contact, rinse with abundant quantities of water. In case of eye irritation, seek medical advice. In case of accidental ingestion, seek medical advice immediately and show the leaflet or the label to the physician.

Spray preferably in a well ventilated area.

Flammable. Do not spray on naked flame or any incandescent material. Do not smoke while handling the veterinary medicinal product.

Use during pregnancy or lactation

The safety of the veterinary medicinal product has not been established during pregnancy and lactation. Systemic absorption of hydrocortisone aceponate being negligible, it is unlikely for teratogenic, foetotoxic, maternotoxic effects to happen at the recommended dosage in dogs.

Use only according to the risk-benefit assessment by the responsible veterinarian.

Interactions

In the absence of information, it is recommended not to apply other topical preparations simultaneously on the same lesions.